- call +1-201-465-4211
- email sales@mrinsights.biz
HGH, produced by the pituitary gland, spurs growth in children and adolescents. It also helps to regulate body composition, body fluids, muscle and bone growth, sugar and fat metabolism, and possibly heart function. Produced synthetically, HGH is the active ingredient in a number of prescription drugs and in other products available widely over the Internet.
Scope of the Report:
This report focuses on the Human Growth Hormone Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Human growth hormone is a peptide hormone, stimulating growth in children and adolescents, and is produced by the pituitary gland. It helps in the growth of bones and muscles by specific cellular differentiation. Apart from stimulating growth, the human growth hormone also regulates carbohydrate metabolism, protein metabolism and fat metabolism. Moreover, the usage of human growth hormone drugs in growth hormone deficient patient has shown significant positive results on the patient’s working capacity, mental alertness and memory. The over secretion of growth hormone leads to gigantism and its deficiency causes dwarfism. The human growth hormone drugs are developed and manufactured by recombinant DNA technology. Earlier, these drugs were mostly used as replacement therapy in pediatric and adult patients, having the deficiency of growth hormones. However, the technological advancements and increased research and development in growth hormone drugs, have resulted in the development of anti-aging drugs and performance enhancers.
The worldwide market for Human Growth Hormone Drugs is expected to grow at a CAGR of roughly 7.5% over the next five years, will reach 57100 million US$ in 2023, from 37000 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Eli Lilly and Company (US)
Ferring Holding SA (Switzerland)
Genentech, Inc. (US)
GeneScience Pharmaceuticals Co., Ltd. (China)
Merck KgaA (Germany)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (US)
Sandoz International GmbH (Germany)
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Norditropin
Genotropin
Humatrope
Saizen
Omnitrope
Somatropin Biopartners
Market Segment by Applications, can be divided into
Prader-Willi Syndrome
Turner Syndrome
Short Stature Homeobox Gene
Small for Gestational Age
Chronic Renal Insufficiency
Short Bowel Syndrome
There are 15 Chapters to deeply display the global Human Growth Hormone Drugs market.
Chapter 1, to describe Human Growth Hormone Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Human Growth Hormone Drugs, with sales, revenue, and price of Human Growth Hormone Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Human Growth Hormone Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Human Growth Hormone Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Human Growth Hormone Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Human Growth Hormone Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Norditropin
1.2.2 Genotropin
1.2.3 Humatrope
1.2.4 Saizen
1.2.5 Omnitrope
1.2.6 Somatropin Biopartners
1.3 Market Analysis by Applications
1.3.1 Prader-Willi Syndrome
1.3.2 Turner Syndrome
1.3.3 Short Stature Homeobox Gene
1.3.4 Small for Gestational Age
1.3.5 Chronic Renal Insufficiency
1.3.6 Short Bowel Syndrome
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Eli Lilly and Company (US)
2.1.1 Business Overview
2.1.2 Human Growth Hormone Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly and Company (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Ferring Holding SA (Switzerland)
2.2.1 Business Overview
2.2.2 Human Growth Hormone Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Ferring Holding SA (Switzerland) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Genentech, Inc. (US)
2.3.1 Business Overview
2.3.2 Human Growth Hormone Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Genentech, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GeneScience Pharmaceuticals Co., Ltd. (China)
2.4.1 Business Overview
2.4.2 Human Growth Hormone Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 GeneScience Pharmaceuticals Co., Ltd. (China) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Merck KgaA (Germany)
2.5.1 Business Overview
2.5.2 Human Growth Hormone Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Merck KgaA (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novo Nordisk A/S (Denmark)
2.6.1 Business Overview
2.6.2 Human Growth Hormone Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novo Nordisk A/S (Denmark) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer, Inc. (US)
2.7.1 Business Overview
2.7.2 Human Growth Hormone Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer, Inc. (US) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sandoz International GmbH (Germany)
2.8.1 Business Overview
2.8.2 Human Growth Hormone Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Sandoz International GmbH (Germany) Human Growth Hormone Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Growth Hormone Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Human Growth Hormone Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Human Growth Hormone Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Growth Hormone Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Human Growth Hormone Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Human Growth Hormone Drugs Market Analysis by Regions
4.1 Global Human Growth Hormone Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Human Growth Hormone Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Human Growth Hormone Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
4.5 South America Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
5 North America Human Growth Hormone Drugs by Countries
5.1 North America Human Growth Hormone Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Human Growth Hormone Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Human Growth Hormone Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
6 Europe Human Growth Hormone Drugs by Countries
6.1 Europe Human Growth Hormone Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Human Growth Hormone Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Human Growth Hormone Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
6.3 UK Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
6.4 France Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Human Growth Hormone Drugs by Countries
7.1 Asia-Pacific Human Growth Hormone Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Human Growth Hormone Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Human Growth Hormone Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
7.5 India Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
8 South America Human Growth Hormone Drugs by Countries
8.1 South America Human Growth Hormone Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Human Growth Hormone Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Human Growth Hormone Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Human Growth Hormone Drugs by Countries
9.1 Middle East and Africa Human Growth Hormone Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Human Growth Hormone Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Human Growth Hormone Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Human Growth Hormone Drugs Sales and Growth Rate (2013-2018)
10 Global Human Growth Hormone Drugs Market Segment by Type
10.1 Global Human Growth Hormone Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Human Growth Hormone Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Human Growth Hormone Drugs Revenue and Market Share by Type (2013-2018)
10.2 Norditropin Sales Growth and Price
10.2.1 Global Norditropin Sales Growth (2013-2018)
10.2.2 Global Norditropin Price (2013-2018)
10.3 Genotropin Sales Growth and Price
10.3.1 Global Genotropin Sales Growth (2013-2018)
10.3.2 Global Genotropin Price (2013-2018)
10.4 Humatrope Sales Growth and Price
10.4.1 Global Humatrope Sales Growth (2013-2018)
10.4.2 Global Humatrope Price (2013-2018)
10.5 Saizen Sales Growth and Price
10.5.1 Global Saizen Sales Growth (2013-2018)
10.5.2 Global Saizen Price (2013-2018)
10.6 Omnitrope Sales Growth and Price
10.6.1 Global Omnitrope Sales Growth (2013-2018)
10.6.2 Global Omnitrope Price (2013-2018)
10.7 Somatropin Biopartners Sales Growth and Price
10.7.1 Global Somatropin Biopartners Sales Growth (2013-2018)
10.7.2 Global Somatropin Biopartners Price (2013-2018)
11 Global Human Growth Hormone Drugs Market Segment by Application
11.1 Global Human Growth Hormone Drugs Sales Market Share by Application (2013-2018)
11.2 Prader-Willi Syndrome Sales Growth (2013-2018)
11.3 Turner Syndrome Sales Growth (2013-2018)
11.4 Short Stature Homeobox Gene Sales Growth (2013-2018)
11.5 Small for Gestational Age Sales Growth (2013-2018)
11.6 Chronic Renal Insufficiency Sales Growth (2013-2018)
11.7 Short Bowel Syndrome Sales Growth (2013-2018)
12 Human Growth Hormone Drugs Market Forecast (2018-2023)
12.1 Global Human Growth Hormone Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Human Growth Hormone Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Human Growth Hormone Drugs Market Forecast (2018-2023)
12.2.2 Europe Human Growth Hormone Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Human Growth Hormone Drugs Market Forecast (2018-2023)
12.2.4 South America Human Growth Hormone Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Human Growth Hormone Drugs Market Forecast (2018-2023)
12.3 Human Growth Hormone Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Human Growth Hormone Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Human Growth Hormone Drugs Market Share Forecast by Type (2018-2023)
12.4 Human Growth Hormone Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Human Growth Hormone Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Human Growth Hormone Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Human Growth Hormone Drugs Picture
Table Product Specifications of Human Growth Hormone Drugs
Figure Global Sales Market Share of Human Growth Hormone Drugs by Types
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
